Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study von Perl, Alexander E, MD, Altman, Jessica K, MD, Cortes, Jorge, MD, Smith, Catherine, MD, Litzow, Mark, MD, Baer, Maria R, MD, Claxton, David, Prof, Erba, Harry P, Prof, Gill, Stan, PhD, Goldberg, Stuart, MD, Jurcic, Joseph G, Prof, Larson, Richard A, Prof, Liu, Chaofeng, PhD, Ritchie, Ellen, MD, Schiller, Gary, MD, Spira, Alexander I, MD, Strickland, Stephen A, MD, Tibes, Raoul, MD, Ustun, Celalettin, MD, Wang, Eunice S, Prof, Stuart, Robert, Prof, Röllig, Christoph, MD, Neubauer, Andreas, Prof, Martinelli, Giovanni, Prof, Bahceci, Erkut, MD, Levis, Mark, Dr

Volltext

Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid von Park, Jae H., Qiao, Baozhen, Panageas, Katherine S., Schymura, Maria J., Jurcic, Joseph G., Rosenblat, Todd L., Altman, Jessica K., Douer, Dan, Rowe, Jacob M., Tallman, Martin S.

Volltext

Targeted Alpha-Particle Therapy for Hematologic Malignancies von Jurcic, Joseph G.

Volltext

Targeted Alpha-Particle Therapy for Hematologic Malignancies von Jurcic, Joseph G.

Volltext

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia von Maslak, Peter G., Dao, Tao, Bernal, Yvette, Chanel, Suzanne M., Zhang, Rong, Frattini, Mark, Rosenblat, Todd, Jurcic, Joseph G., Brentjens, Renier J., Arcila, Maria E., Rampal, Raajit, Park, Jae H., Douer, Dan, Katz, Laura, Sarlis, Nicholas, Tallman, Martin S., Scheinberg, David A.

Volltext

Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS) von Abel, Gregory A, Efficace, Fabio, Buckstein, Rena J, Tinsley, Sara, Jurcic, Joseph G, Martins, Yolanda, Steensma, David P, Watts, Corey D, Raza, Azra, Lee, Stephanie J, List, Alan F, Klaassen, Robert J

Volltext

Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia von Sekeres, Mikkael A, Lancet, Jeffrey E, Wood, Brent L, Grove, Laurie E, Sandalic, Larissa, Sievers, Eric L, Jurcic, Joseph G

Volltext

Rewriting the rules for care of MDS and AML patients in the time of COVID-19 von Raza, Azra, Assal, Amer, Ali, Abdullah M., Jurcic, Joseph G.

Volltext

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes von Fenaux, Pierre, Platzbecker, Uwe, Mufti, Ghulam J, Garcia-Manero, Guillermo, Buckstein, Rena, Santini, Valeria, Díez-Campelo, María, Finelli, Carlo, Cazzola, Mario, Ilhan, Osman, Sekeres, Mikkael A, Falantes, José F, Arrizabalaga, Beatriz, Salvi, Flavia, Giai, Valentina, Vyas, Paresh, Bowen, David, Selleslag, Dominik, DeZern, Amy E, Jurcic, Joseph G, Germing, Ulrich, Götze, Katharina S, Quesnel, Bruno, Beyne-Rauzy, Odile, Cluzeau, Thomas, Voso, Maria-Teresa, Mazure, Dominiek, Vellenga, Edo, Greenberg, Peter L, Hellström-Lindberg, Eva, Zeidan, Amer M, Adès, Lionel, Verma, Amit, Savona, Michael R, Laadem, Abderrahmane, Benzohra, Aziz, Zhang, Jennie, Rampersad, Anita, Dunshee, Diana R, Linde, Peter G, Sherman, Matthew L, Komrokji, Rami S, List, Alan F

Volltext

Pentostatin, Cyclophosphamide, and Rituximab Is an Active, Well-Tolerated Regimen for Patients With Previously Treated Chronic Lymphocytic Leukemia von LAMANNA, Nicole, KALAYCIO, Matt, SCHEINBERG, David A, WEISS, Mark A, MASLAK, Peter, JURCIC, Joseph G, HEANEY, Mark, BRENTJENS, Renier, ZELENETZ, Andrew D, HORGAN, Denise, GENCARELLI, Alison, PANAGEAS, Katherine S

Volltext

Androgen Maintenance Therapy for Acute Myeloid Leukemia von Jurcic, Joseph G

Volltext

Targeted alpha-particle immunotherapy for acute myeloid leukemia von Jurcic, Joseph G, Rosenblat, Todd L

Volltext

Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study von Sallman, David A, Al Malki, Monzr M, Asch, Adam S, Wang, Eunice S, Jurcic, Joseph G, Bradley, Terrence J, Flinn, Ian W, Pollyea, Daniel A, Kambhampati, Suman, Tanaka, Tiffany N, Zeidner, Joshua F, Garcia-Manero, Guillermo, Jeyakumar, Deepa, Komrokji, Rami, Lancet, Jeffrey, Kantarjian, Hagop M, Gu, Lin, Zhang, Yajia, Tan, Anderson, Chao, Mark, O'Hear, Carol, Ramsingh, Giridharan, Lal, Indu, Vyas, Paresh, Daver, Naval G

Volltext

Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab von Rosenblat, Todd L, McDevitt, Michael R, Carrasquillo, Jorge A, Pandit-Taskar, Neeta, Frattini, Mark G, Maslak, Peter G, Park, Jae H, Douer, Dan, Cicic, Dragan, Larson, Steven M, Scheinberg, David A, Jurcic, Joseph G

Volltext

Sequential Therapy With Fludarabine, High-Dose Cyclophosphamide, and Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia Produces High-Quality Responses: M... von LAMANNA, Nicole, JURCIC, Joseph G, ZELENETZ, Andrew D, WEISS, Mark A, NOY, Ariela, MASLAK, Peter, GENCARELLI, Alison N, PANAGEAS, Katherine S, HEANEY, Mark L, BRENTJENS, Renier J, GOLDE, David W, SCHEINBERG, David A

Volltext

Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML von Pratz, Keith W, Cherry, Mohamad, Altman, Jessica K, Cooper, Brenda W, Podoltsev, Nikolai A, Cruz, Jose Carlos, Lin, Tara L, Schiller, Gary J, Jurcic, Joseph G, Asch, Adam, Wu, Ruishan, Hill, Jason E, Gill, Stanley C, James, Angela J, Rich, Elizabeth Shima, Hasabou, Nahla, Perl, Alexander E, Levis, Mark J

Volltext

Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia von ROSENBLAT, Todd L, MCDEVITT, Michael R, LARSON, Steven M, SCHEINBERG, David A, JURCIC, Joseph G, MULFORD, Deborah A, PANDIT-TASKAR, Neeta, DIVGI, Chaitanya R, PANAGEAS, Katherine S, HEANEY, Mark L, CHANEL, Suzanne, MORGENSTERN, Alfred, SGOUROS, George

Volltext

Severe mechanical hemolysis in a patient with thalassemia minor who had undergone inappropriate splenectomy von Falchi, Lorenzo, Grillo, Lola M., Diuguid-Gerber, Jillian L., Eisenberger, Andrew B., Jurcic, Joseph G.

Volltext

Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts von Zeidan, Amer M., Platzbecker, Uwe, Garcia-Manero, Guillermo, Sekeres, Mikkael A., Fenaux, Pierre, DeZern, Amy E., Greenberg, Peter L., Savona, Michael R., Jurcic, Joseph G., Verma, Amit K., Mufti, Ghulam J., Buckstein, Rena, Santini, Valeria, Shetty, Jeevan K., Ito, Rodrigo, Zhang, Jennie, Zhang, George, Ha, Xianwei, Backstrom, Jay T., Komrokji, Rami S.

Volltext

What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia? von Jurcic, Joseph G.

Volltext